NETosis as an oncologic therapeutic target: a mini review

Neutrophil Extracellular Traps (NETs) are a key form of pro-inflammatory cell death of neutrophils characterized by the extrusion of extracellular webs of DNA containing bactericidal killing enzymes. NETosis is heavily implicated as a key driver of host damage in autoimmune diseases where injurious...

Full description

Bibliographic Details
Main Authors: Sarah Jaboury, Kenny Wang, Kim Maree O’Sullivan, Joshua Daniel Ooi, Gwo Yaw Ho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1170603/full
_version_ 1827965316756406272
author Sarah Jaboury
Kenny Wang
Kim Maree O’Sullivan
Joshua Daniel Ooi
Gwo Yaw Ho
Gwo Yaw Ho
author_facet Sarah Jaboury
Kenny Wang
Kim Maree O’Sullivan
Joshua Daniel Ooi
Gwo Yaw Ho
Gwo Yaw Ho
author_sort Sarah Jaboury
collection DOAJ
description Neutrophil Extracellular Traps (NETs) are a key form of pro-inflammatory cell death of neutrophils characterized by the extrusion of extracellular webs of DNA containing bactericidal killing enzymes. NETosis is heavily implicated as a key driver of host damage in autoimmune diseases where injurious release of proinflammatory enzymes damage surrounding tissue and releases 70 known autoantigens. Recent evidence shows that both neutrophils and NETosis have a role to play in carcinogenesis, both indirectly through triggering DNA damage through inflammation, and directly contributing to a pro-tumorigenic tumor microenvironment. In this mini-review, we summarize the current knowledge of the various mechanisms of interaction and influence between neutrophils, with particular attention to NETosis, and cancer cells. We will also highlight the potential avenues thus far explored where we can intercept these processes, with the aim of identifying promising prospective targets in cancer treatment to be explored in further studies.
first_indexed 2024-04-09T17:31:07Z
format Article
id doaj.art-20e47fac67ae414a929e391132579c14
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T17:31:07Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-20e47fac67ae414a929e391132579c142023-04-18T04:19:05ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11706031170603NETosis as an oncologic therapeutic target: a mini reviewSarah Jaboury0Kenny Wang1Kim Maree O’Sullivan2Joshua Daniel Ooi3Gwo Yaw Ho4Gwo Yaw Ho5Department of Oncology, Monash Health, Clayton, VIC, AustraliaSchool of Clinical Sciences, Monash University, Melbourne, VIC, AustraliaSchool of Clinical Sciences, Monash University, Melbourne, VIC, AustraliaSchool of Clinical Sciences, Monash University, Melbourne, VIC, AustraliaDepartment of Oncology, Monash Health, Clayton, VIC, AustraliaSchool of Clinical Sciences, Monash University, Melbourne, VIC, AustraliaNeutrophil Extracellular Traps (NETs) are a key form of pro-inflammatory cell death of neutrophils characterized by the extrusion of extracellular webs of DNA containing bactericidal killing enzymes. NETosis is heavily implicated as a key driver of host damage in autoimmune diseases where injurious release of proinflammatory enzymes damage surrounding tissue and releases 70 known autoantigens. Recent evidence shows that both neutrophils and NETosis have a role to play in carcinogenesis, both indirectly through triggering DNA damage through inflammation, and directly contributing to a pro-tumorigenic tumor microenvironment. In this mini-review, we summarize the current knowledge of the various mechanisms of interaction and influence between neutrophils, with particular attention to NETosis, and cancer cells. We will also highlight the potential avenues thus far explored where we can intercept these processes, with the aim of identifying promising prospective targets in cancer treatment to be explored in further studies.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1170603/fullneutrophilNETosiscancerinnate immunitytumor microenvironment
spellingShingle Sarah Jaboury
Kenny Wang
Kim Maree O’Sullivan
Joshua Daniel Ooi
Gwo Yaw Ho
Gwo Yaw Ho
NETosis as an oncologic therapeutic target: a mini review
Frontiers in Immunology
neutrophil
NETosis
cancer
innate immunity
tumor microenvironment
title NETosis as an oncologic therapeutic target: a mini review
title_full NETosis as an oncologic therapeutic target: a mini review
title_fullStr NETosis as an oncologic therapeutic target: a mini review
title_full_unstemmed NETosis as an oncologic therapeutic target: a mini review
title_short NETosis as an oncologic therapeutic target: a mini review
title_sort netosis as an oncologic therapeutic target a mini review
topic neutrophil
NETosis
cancer
innate immunity
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1170603/full
work_keys_str_mv AT sarahjaboury netosisasanoncologictherapeutictargetaminireview
AT kennywang netosisasanoncologictherapeutictargetaminireview
AT kimmareeosullivan netosisasanoncologictherapeutictargetaminireview
AT joshuadanielooi netosisasanoncologictherapeutictargetaminireview
AT gwoyawho netosisasanoncologictherapeutictargetaminireview
AT gwoyawho netosisasanoncologictherapeutictargetaminireview